Stakeholders offer competing feedback on how FDA should regulate genAI devices - RAPS

The FDA is hearing different opinions on how it should regulate AI medical devices—a crucial question for patient safety and innovation. This affects anyone who might use AI-powered medical tools and the companies developing them.